189 related articles for article (PubMed ID: 12021185)
21. Regulation and tissue distribution of the human sodium iodide symporter gene.
Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
[TBL] [Abstract][Full Text] [Related]
22. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
23. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
[TBL] [Abstract][Full Text] [Related]
24. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
25. Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells.
Nakanishi T; Kohroki J; Suzuki S; Ishizaki J; Hiromori Y; Takasuga S; Itoh N; Watanabe Y; Utoguchi N; Tanaka K
J Clin Endocrinol Metab; 2002 Jun; 87(6):2830-7. PubMed ID: 12050258
[TBL] [Abstract][Full Text] [Related]
26. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.
Kogai T; Endo T; Saito T; Miyazaki A; Kawaguchi A; Onaya T
Endocrinology; 1997 Jun; 138(6):2227-32. PubMed ID: 9165005
[TBL] [Abstract][Full Text] [Related]
27. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
[TBL] [Abstract][Full Text] [Related]
28. Ontogenic changes in human placental sodium iodide symporter expression.
Li H; Patel J; Mortimer RH; Richard K
Placenta; 2012 Nov; 33(11):946-8. PubMed ID: 22954554
[TBL] [Abstract][Full Text] [Related]
29. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
30. Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells.
Bidart JM; Lacroix L; Evain-Brion D; Caillou B; Lazar V; Frydman R; Bellet D; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4367-72. PubMed ID: 11095481
[TBL] [Abstract][Full Text] [Related]
31. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene.
Suzuki K; Mori A; Saito J; Moriyama E; Ullianich L; Kohn LD
Endocrinology; 1999 Nov; 140(11):5422-30. PubMed ID: 10537174
[TBL] [Abstract][Full Text] [Related]
32. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
33. Expression of adrenomedullin by human placental cytotrophoblasts and choriocarcinoma JAr cells.
Moriyama T; Otani T; Maruo T
J Clin Endocrinol Metab; 2001 Aug; 86(8):3958-61. PubMed ID: 11502838
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.
Scholz IV; Cengic N; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1108-16. PubMed ID: 15001595
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotropin stimulates thyroid hormone secretion, iodide uptake, organification, and adenosine 3',5'-monophosphate formation in cultured human thyrocytes.
Kraiem Z; Sadeh O; Blithe DL; Nisula BC
J Clin Endocrinol Metab; 1994 Aug; 79(2):595-9. PubMed ID: 8045981
[TBL] [Abstract][Full Text] [Related]
36. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells.
Passon N; Puppin C; Lavarone E; Bregant E; Franzoni A; Hershman JM; Fenton MS; D'Agostino M; Durante C; Russo D; Filetti S; Damante G
Thyroid; 2012 May; 22(5):487-93. PubMed ID: 22510021
[TBL] [Abstract][Full Text] [Related]
38. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
Eng PH; Cardona GR; Fang SL; Previti M; Alex S; Carrasco N; Chin WW; Braverman LE
Endocrinology; 1999 Aug; 140(8):3404-10. PubMed ID: 10433193
[TBL] [Abstract][Full Text] [Related]
39. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
[TBL] [Abstract][Full Text] [Related]
40. Hormonal regulation of estrogen receptor alpha and beta gene expression in human granulosa-luteal cells in vitro.
Chiang CH; Cheng KW; Igarashi S; Nathwani PS; Leung PC
J Clin Endocrinol Metab; 2000 Oct; 85(10):3828-39. PubMed ID: 11061546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
